Roche Corleen M. 4
4 · Immunome Inc. · Filed Jun 21, 2022
Insider Transaction Report
Form 4
Immunome Inc.IMNM
Roche Corleen M.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-06-16+70,000→ 70,000 totalExercise: $3.42Exp: 2032-06-16→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]With respect to the options to purchase 40,000 shares, 25% of the shares subject to such options vest on June 16, 2023, and one-thirty-sixth (1/36th) of the remaining shares subject to such options shall vest every month thereafter. With respect to the remaining options to purchase 30,000 shares, 50% of the shares subject to such options vest on June 16, 2023, and the remaining 50% of the shares subject to such options vest on June 16, 2024.